Drug Recalls

Here you'll find every drug recall the FDA has issued, including prescription medications, over-the-counter drugs, compounded pharmacy products, and dietary supplements. We've been tracking these since 2006 and our database updates several times a day so you're always looking at current information.

Drugs get recalled for a number of reasons: contamination during manufacturing, incorrect potency or dosage, failed quality testing (like dissolution or stability tests), sterility problems in injectable products, or labeling and packaging errors that could cause someone to take the wrong dose. If you find a product on this list that you use, please follow the instructions provided by the FDA to take the necessary precautions.

17,529 total recalls
2 this month

Showing 701–720 of 17,529 recalls

March 24, 2025· Amerisource Health Services LLC

Recalled Item: Voriconazole Tablets

The Issue: cGMP Deviations: Received notification from their supplier requesting

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 21, 2025· Somerset Therapeutics Private Limited

Recalled Item: Haloperidol Decanoate Injection 100mg/mL

The Issue: Lack of Assurance of Sterility: Media fill with

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
March 21, 2025· Somerset Therapeutics Private Limited

Recalled Item: Haloperidol Decanoate Injection 50mg/mL

The Issue: Lack of Assurance of Sterility: Media fill with

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
March 21, 2025· Zydus Pharmaceuticals (USA) Inc

Recalled Item: Venlafaxine Tablets

The Issue: Foreign Object Contamination

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
March 21, 2025· Somerset Therapeutics Private Limited

Recalled Item: Methocarbamol Injection USP 1

The Issue: Lack of Assurance of Sterility: Media fill with

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
March 21, 2025· Somerset Therapeutics Private Limited

Recalled Item: Haloperidol Decanoate Injection

The Issue: Lack of Assurance of Sterility: Media fill with

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
March 21, 2025· Somerset Therapeutics Private Limited

Recalled Item: Haloperidol Decanoate Injection 50mg/mL

The Issue: Lack of Assurance of Sterility: Media fill with

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
March 17, 2025· BIOCON PHARMA INC

Recalled Item: Atorvastatin Calcium Tablets USP 40 mg

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
March 13, 2025· Dr. Reddy's Laboratories, Inc.

Recalled Item: Levetiracetam 0.75% in Sodium Chloride Injection 1

The Issue: LABELING: LABEL MIX-UP: The infusion bag is incorrectly

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
March 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Cetirizine Hydrochloride Tablets

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
March 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Ranolazine Extended-Release Tablets 1000mg

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
March 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Pravastatin Sodium Tablets

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
March 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Fenofibrate Capsules 67 mg

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
March 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Frovatriptan Succinate Tablets 2.5mg

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
March 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Naproxen Sodium Tablets

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
March 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Pravastatin Sodium Tablets

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
March 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Metformin Hydrochloride Extended-Release Tablets 1000mg

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
March 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Solifenacin Succinate Tablets 5mg

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
March 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Gabapentin Tablets 600mg

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
March 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Prochlorperazine Maleate Tablets

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund